Patient and Provider Interventions for Managing Osteoarthritis in Primary Care
Launched by DUKE UNIVERSITY · Sep 14, 2011
Trial Information
Current as of August 11, 2025
Completed
Keywords
ClinConnect Summary
Evidence-based guidelines emphasize that adequate management of osteoarthritis (OA) requires a combination of both medical and behavioral modalities. However, many of the recommended guidelines are not regularly incorporated into clinical practice, and the recommended behavioral strategies (e.g. exercise and weight management) are not practiced by most patients. Prior studies have examined strategies for improving patient behaviors to manage OA-related symptoms, but few studies have examined provider-based interventions specifically for patients with OA, or combinations of patient- and prov...
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Radiographic evidence of hip OA and/or radiographic evidence of or meets clinical criteria for knee OA
- • Current joint (hip and/or knee) symptoms
- • BMI \>= 25
- • Physically inactive
- Exclusion Criteria:
- • Diagnosis of rheumatoid arthritis, fibromyalgia, or other systemic rheumatic disease
- • Diagnosis of a motor neuron disease, Parkinson's disease, multiple sclerosis, or Paget's disease
- • Diagnosis of metastatic cancer
- • Hospitalized for a stroke, myocardial infarction or coronary artery revascularization in the past 3 months
- • On waiting list for or planning arthroplasty
- • Total joint replacement (hip or knee) surgery, other hip or knee surgery, meniscus tear (verified by MRI), or ACL tear in the past 6 months
- • History of gout in hip or knee
- • Quadriplegia or paraplegia
- • Active diagnosis of psychosis or serious personality disorder
- • Diagnosis of dementia or other memory loss condition
- • Current, uncontrolled substance abuse disorder
- • Severly impaired speech or hearing (patients must be able to respond to phone calls)
- • No access to a telephone
- • Inability to understand and speak English
- • Blindness
- • Resident in nursing home
- • Serious / terminal illness as indicated by referral to hospice or palliative care
- • For females: currently pregnant or planning to become pregnant
- • No visit to their Duke primary health care provider in the last 18 months
- • Participating in another OA intervention of other lifestyle change study
- • Other self-reported medical problem that would prohibit participation in the study
- • Other health condition or personal issue judged by a study team member or primary care physician to make the patient inappropriate for study participation
About Duke University
Duke University, a leading academic and research institution located in Durham, North Carolina, is renowned for its commitment to advancing healthcare through innovative clinical research. With a strong emphasis on interdisciplinary collaboration, Duke conducts a wide array of clinical trials aimed at developing cutting-edge therapies and improving patient outcomes across various medical fields. The university's Clinical Research Institute provides comprehensive support for trial design, implementation, and regulatory compliance, ensuring that all research adheres to the highest ethical and scientific standards. Duke’s dedication to translating research findings into effective clinical practices underscores its role as a pivotal contributor to the global medical community.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Durham, North Carolina, United States
Patients applied
Trial Officials
Kelli D Allen, PhD
Principal Investigator
Duke University
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials